Affordable Access

Nicotine attenuates arachidonic acid-induced neurotoxicity in cultured spinal cord neurons.

Authors
  • Garrido, R
  • Malecki, A
  • Hennig, B
  • Toborek, M
Type
Published Article
Journal
Brain Research
Publisher
Elsevier
Publication Date
Apr 07, 2000
Volume
861
Issue
1
Pages
59–68
Identifiers
PMID: 10751565
Source
Medline
License
Unknown

Abstract

Arachidonic acid release from cellular membranes due to spinal cord trauma may be one of the principal destructive events that can lead to progressive injury to spinal cord tissue. Exposure to arachidonic acid can compromise neuronal survival and viability. Because nicotine is known to be a neuroprotective agent, we propose that it can prevent arachidonic acid-induced neurotoxicity. To study this hypothesis, effects of nicotine on mitochondrial function, cellular energy content and apoptotic cell death were measured in cultured spinal cord neurons treated with arachidonic acid. Nicotine attenuated arachidonic acid-induced compromised cell viability and cellular ATP levels in spinal cord neurons. Nicotine exerted these protective effects when used at the concentration of 10 microM and only after a 2-h pre-treatment before a co-exposure to arachidonic acid. Antagonists of nicotinic receptors, such as alpha-bungarotoxin or mecamylamine, only partially reversed these neuroprotective effects of nicotine. In addition, nicotine prevented arachidonic acid-induced activation of caspase-3 activity and apoptotic cell death. These results indicate that nicotine pre-treatment can exert a protective effect against arachidonic acid-induced injury to spinal cord neurons.

Report this publication

Statistics

Seen <100 times